tradingkey.logo
tradingkey.logo
Search

Skye Bioscience Inc

SKYE
Add to Watchlist
0.569USD
-0.012-2.03%
Close 07-31 16:00ETQuotes delayed by 15 min
19.98MMarket Cap
LossP/E TTM

SKYE Financials

See Skye Bioscience Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Skye Bioscience Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.32/-0.31
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.41
-93.65%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-12.58%-0.32
-49.32%-0.36
-220.21%-0.32
-117.45%-0.44
-56.20%-0.28
31.62%-0.24
96.83%-0.10
74.45%-0.20
86.94%-0.18
89.43%-0.36
---3.17
---0.80
---1.37
---3.37
---4.83
----
----
----
----
----
Net Profit
-12.66%-12.51M
-48.18%-14.44M
-227.19%-12.75M
-123.02%-17.62M
-121.20%-11.10M
-120.51%-9.75M
84.37%-3.90M
-153.99%-7.90M
2.86%-5.02M
55.32%-4.42M
-697.68%-24.95M
9.00%-3.11M
-69.79%-5.17M
-293.65%-9.89M
-71.38%-3.13M
-68.93%-3.42M
-40.86%-3.04M
-67.29%-2.51M
-40.73%-1.82M
-42.51%-2.02M
Debt to assets ratio
--1.29%
----
----
----
----
-100.00%0.00%
-100.00%0.00%
37.41%5.57%
40.59%4.86%
80.48%36.62%
--26.71%
--4.05%
--3.46%
--20.29%
--85.59%
----
----
----
----
----
Operating profit
-7.78%-12.67M
-20.64%-14.90M
-39.30%-13.26M
-117.05%-18.24M
-91.14%-11.76M
-202.17%-12.35M
61.46%-9.52M
-180.67%-8.41M
-98.45%-6.15M
-32.77%-4.09M
-745.43%-24.71M
6.95%-2.99M
-7.35%-3.10M
-25.03%-3.08M
-60.64%-2.92M
-75.90%-3.22M
-66.24%-2.89M
-86.64%-2.46M
-18.26%-1.82M
-49.89%-1.83M
Net Profit
-12.66%-12.51M
-48.18%-14.44M
-227.19%-12.75M
-123.02%-17.62M
-121.20%-11.10M
-120.51%-9.75M
84.37%-3.90M
-153.99%-7.90M
2.86%-5.02M
55.32%-4.42M
-697.68%-24.95M
9.00%-3.11M
-69.79%-5.17M
-293.65%-9.89M
-71.38%-3.13M
-68.93%-3.42M
-40.86%-3.04M
-67.29%-2.51M
-40.73%-1.82M
-42.51%-2.02M
Current assets
-70.54%18.57M
-61.75%27.09M
-49.97%39.92M
-41.86%50.58M
-33.35%63.03M
507.92%70.83M
422.09%79.81M
4496.88%87.00M
2024.75%94.57M
30.27%11.65M
469.68%15.29M
-60.35%1.89M
-36.35%4.45M
-6.95%8.94M
-76.53%2.68M
-12.70%4.77M
29.94%6.99M
260.76%9.61M
162.93%11.43M
2320.19%5.47M
Total current liabilities
95.60%10.40M
89.11%8.21M
48.78%8.37M
-41.97%8.31M
-66.33%5.32M
-68.79%4.34M
-59.00%5.62M
45.90%14.32M
68.68%15.80M
14.70%13.90M
123.23%13.72M
87.45%9.82M
124.01%9.37M
209.78%12.12M
309.28%6.15M
238.27%5.24M
202.08%4.18M
396.98%3.91M
24.00%1.50M
-28.17%1.55M
Total assets
-70.03%19.42M
-61.09%28.31M
-49.32%41.32M
-40.22%52.16M
-31.68%64.79M
509.39%72.76M
422.52%81.54M
3802.67%87.26M
1967.51%94.84M
31.05%11.94M
443.93%15.60M
-54.99%2.24M
-36.39%4.59M
-7.55%9.11M
-75.45%2.87M
-9.49%4.97M
33.56%7.21M
268.87%9.86M
168.69%11.69M
2315.46%5.49M
Total liabilities
87.72%10.40M
79.73%8.29M
48.08%8.49M
-41.30%8.48M
-65.25%5.54M
-67.23%4.61M
-58.79%5.73M
44.16%14.45M
70.29%15.95M
16.12%14.07M
126.02%13.91M
90.26%10.03M
121.06%9.37M
203.67%12.12M
79.81%6.15M
63.80%5.27M
45.12%4.24M
79.70%3.99M
37.10%3.42M
-3.15%3.22M
Total equity
-84.79%9.01M
-70.62%20.02M
-56.68%32.84M
-40.01%43.68M
-24.89%59.25M
3296.88%68.15M
4371.49%75.80M
1034.74%72.81M
1750.08%78.88M
29.13%-2.13M
151.61%1.70M
-2480.73%-7.79M
-260.79%-4.78M
-151.30%-3.01M
-139.75%-3.28M
-113.29%-301.82K
19.95%2.97M
1200.88%5.86M
345.93%8.26M
173.39%2.27M
Net operating income
6.83%-8.56M
-19.50%-9.77M
-153.94%-13.36M
-51.49%-10.75M
-95.10%-9.19M
-112.58%-8.17M
-29.79%-5.26M
-256.13%-7.09M
-15.94%-4.71M
21.08%-3.84M
-97.16%-4.05M
31.34%-1.99M
-39.32%-4.06M
-147.43%-4.87M
-38.35%-2.06M
-73.57%-2.90M
-116.22%-2.91M
-10.24%-1.97M
24.70%-1.49M
-62.58%-1.67M
Net investment
185.07%10.90M
-3200.88%-2.80M
651.16%7.97M
-36418.58%-11.86M
-1221.66%-12.81M
1388.44%90.41K
-234.71%-1.45M
---32.46K
-79.35%1.14M
-100.12%-7.02K
393.13%1.07M
100.00%0.00
276758.63%5.53M
10586.15%5.67M
-1273.20%-366.07K
-16077.76%-84.04K
81.31%-2.00K
-647.41%-54.04K
---26.66K
--526.00
Net financing
---71.53K
103.15%11.41K
--0.00
100.87%18.16K
-100.00%0.00
124.80%5.62K
-100.00%0.00
-1598.41%-2.10M
189149.41%85.65M
-166.32%-22.65K
18211.45%16.63M
-34.37%-123.41K
23.55%-45.31K
140.80%34.16K
-101.24%-91.85K
-105.39%-91.85K
-101.47%-59.26K
-320.32%-83.72K
21.66%7.42M
200.83%1.70M

FAQs

What are the current assets of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its current assets were 27.09M, with a year-on-year change of -61.75.

What are the total assets of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its total assets of Skye Bioscience Inc were 28.31M, with a year-on-year change of -61.09.

What are the total liabilities of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its total liabilities of Skye Bioscience Inc were 8.29M, with a year-on-year change of 79.73.

What is the total equity of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its total equity of Skye Bioscience Inc was 20.02M, with a year-on-year change of -70.62.

What is the net operating income of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its net operating income of Skye Bioscience Inc was -58.16M, with a year-on-year change of -59.67.

What is the net investment of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its net investment of Skye Bioscience Inc was -19.50M, with a year-on-year change of -7839.37.

What is the net financing of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its net financing of Skye Bioscience Inc was 29.57K, with a year-on-year change of -99.96.

What is the Earnings Per Share (EPS) of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.41, with a year-on-year change of -93.65.

What is the net income of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its net income was -55.92M, with a year-on-year change of -110.50.

What is the Return on Equity (ROE) of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its Return on Equity (ROE) was -126.85, with a year-on-year change of -57.61.

What is the Return on Assets (ROA) of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its Return on Assets (ROA) was -110.66, with a year-on-year change of -76.40.

What is the operating profit of Skye Bioscience Inc?

According to Skye Bioscience Inc's FY2025 earnings report, its operating profit was -58.16M, with a year-on-year change of -59.67.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.